Kathryn Romano - Jan 22, 2024 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Signature
/s/ Kathryn Romano
Stock symbol
KRYS
Transactions as of
Jan 22, 2024
Transactions value $
-$194,350
Form type
4
Date filed
1/24/2024, 05:44 PM
Previous filing
May 23, 2023
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRYS Common Stock Options Exercise $131K +2.5K +19.91% $52.26 15.1K Jan 22, 2024 Direct F1
transaction KRYS Common Stock Sale -$325K -2.5K -16.6% $130.00 12.6K Jan 22, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRYS Stock Option (Right to Buy) Options Exercise $0 -2.5K -20% $0.00 10K Jan 22, 2024 Common Stock 2.5K $52.26 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and sales of 2,500 shares with a limit price of $130.00 per share.
F2 The transaction was executed in one trade.
F3 50,000 options were granted that vest in four equal annual installments beginning on January 20, 2021.